ArticleFrontiers in microbiology2017
Comparative Genomics of
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed.
- Integrated Genome Mining and Bioactivity-Guided Isolation of Antimicrobial Peptides from Bacillus amyloliquefaciens BS4.Probiotics and antimicrobial proteins · 2026Article
- Systems-level genomic and functional characterization of lipopeptide biosurfactant pathways in Bacillus albus MITWPUB5.World journal of microbiology & biotechnology · 2026Article
- Biocontrol potentiality and plant growth-promoting traits of endophytic Enterobacter cloacae RO2 isolated from Portulaca oleracea L. against Bipolaris sorokiniana.Scientific reports · 2026Article
- Multifunctional Bioactivity ofCurrent issues in molecular biology · 2026Article
- Comparative genomics and molecular characterization of a multidrug-resistant Corynebacterium glucuronolyticum isolated for the first time from the human genitourinary tract in Latin America.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- Metabolomic profiling of Bacillus amyloliquefaciens MU-10 and its antagonistic effects on Cercospora arachidicola.BMC microbiology · 2026Article
- Genomic Insights into Antimicrobial Biosynthetic Potential ofMicroorganisms · 2026Article
- Genomic sequencing of vineyard-isolatedFrontiers in microbiology · 2026Article
- PGAP2: A comprehensive toolkit for prokaryotic pan-genome analysis based on fine-grained feature networks.Nature communications · 2025Article
- Identification of an antifungal lipopeptide fromMicrobiology spectrum · 2025Article
- Inoculating maize (Zea mays L.) seeds with halotolerant rhizobacteria from wild halophytes improves physiological and biochemical responses of seedlings to salt stress.Biologia futura · 2025Article
- Unveiling the genetic basis of biochemical pathways of plant growth promotion inCurrent research in microbial sciences · 2025Article
- Evolutionary paths toward multi-level convergence of lactic acid bacteria in fructose-rich environments.Communications biology · 2024Article
- Wood fiber biomass pyrolysis solution as a potential tool for plant disease management: A review.Heliyon · 2024Review
- Molecular characterization and antifungal activity of lipopeptides produced from Bacillus subtilis against plant fungal pathogen Alternaria alternata.BMC microbiology · 2023Article
- New Insights on Metabolic Features ofInternational journal of molecular sciences · 2023Article
- Bacillus amyloliquefaciens Increases the GABA in Rice Seed for Upregulation of Type I Collagen in the Skin.Current microbiology · 2023Article
- Effects of a Microbial Restoration Substrate on Plant Growth and Rhizosphere Microbial Community in a Continuous Cropping Poplar.Microorganisms · 2023Article
- Biocontrol potential and action mechanism ofFrontiers in microbiology · 2023Article
- Management of Rhizosphere Microbiota and Plant Production under Drought Stress: A Comprehensive Review.Plants (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Gram positive, non-pathogenic endospore-forming soil inhabiting prokaryote
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.